Interleukin-6 and C-reactive protein are commonly assessed biomarkers linked to illness, obesity, and stressful life events. However, relatively little is known about their heritability. By comparing Caucasian twins from the Midlife in the US project (MIDUS), we estimated the heritability of IL-6, its soluble receptor, and CRP. Based on the hypothesis that adiposity might contribute more to IL-6 than to sIL-6r, we fit heritability models quantifying the extent to which each reflected genetic and environmental factors shared with obesity. Genetic influences on IL-6 and its receptor proved to be distinct. Further, the appearance of a heritable basis for IL-6 was mediated largely via shared paths with obesity. Supporting this conclusion, we confirmed that when unrelated adult controls are carefully matched to twin participants on BMI, age, gender and socioeconomic indices, their IL-6 is similar to the corresponding twins. In contrast, the effect of BMI on CRP was split between shared genetics and environmental influences. In conclusion, IL-6 is strongly affected by factors associated with obesity accounting for its lability and responsiveness to diet, life style and contemporaneous events.
Introduction
The pleiotropic cytokine, interleukin-6 (IL-6), is produced by many cells and tissues, and plays a major role in normal physiology and inflammatory responses. It has been widely employed in research on population health and aging because circulating levels of IL-6 tend to rise in old age, with obesity, and following stressful life events (Fried et al., 1998; Friedman et al., 2005; Kiecolt-Glaser et al., 2003) . It has also been associated with chronic stress and vulnerability to depression (Bob et al., 2010; Lutgendorf et al., 1999; Miller et al., 2002) . Although blood levels of IL-6 are often quantified in isolation, its biological actions are determined by two distinct membrane bound glycoproteins expressed on the surface of target cells: (1) a classical transmembrane IL-6 receptor (mIL-6r), and (2) a signal-transducing non-ligand binding subunit, gp130, which is activated by a complex formed by IL-6 and the soluble form of the IL-6 receptor (sIL-6r) (Kallen, 2002; Peters et al., 1998) . Further, the sIL-6r has also been shown to moderate central actions of IL-6 within the brain (Schöbitz et al., 1995) . Therefore, to more completely understand variation in IL-6 synthesis and responses across individuals, it is important to also quantify the soluble receptor, which was done in the following study.
IL-6 and sIL-6r are coded by different genes and controlled by distinct mechanisms of expression (Crichton et al., 1996; Jones et al., 2001; Lust et al., 1992) . In addition, sIL-6r may be produced either by alternative mRNA splicing or by proteolytic cleavage and shedding from the surface of cells (Jones et al., 2001; Müllberg et al., 1993) . Thus, it is of significance to determine the extent and similarity of the genetic constraints on IL-6 and its soluble receptor. It is known that the magnitude of the IL-6 response in inflammatory conditions can be affected by different single nucleotide polymorphisms (SNPs) associated with the IL-6 gene (Bruunsgaard et al., 2004; Sen et al., 2011; Walston et al., 2007) . Accordingly, an examination of IL-6 responses to a strong inflammatory stimulus yielded high heritability estimates (de Craen et al., 2005) . However, this general conclusion is often, and inappropriately, overgeneralized to all aspects of IL-6 synthesis and release. In the absence of inflammatory stimuli, SNPs have a weak or no association with baseline levels of IL-6 in the blood stream (Bagli et al., 2003; Bennermo et al., 2004; Brull et al., 2001; Burzotta et al., 2001; Herbert et al., 2006; Lieb et al., 2004; Nauck et al., 2002; Sen et al., 2011; Shah et al., 2013; van 
